Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Kopp

Showing results (91-100 of 187) with videos related to

Pageof 19
Sort By:
Thrombosis and Haemostasis|November 8, 2013
In vivo and protease-activated receptor-1-mediated platelet activation but not response to antiplatelet therapy predict two-year outcomes after peripheral angioplasty with stent implantationT Gremmel, S Steiner, D Seidinger, et al.
Ecology|January 25, 2024
Fire sparks upslope range shifts of North Cascades plant speciesRachel N Wilson, Christopher W Kopp, Janneke Hille Ris Lambers, et al.
Platelets|January 15, 2011
Comparison of methods to evaluate aspirin-mediated platelet inhibition after percutaneous intervention with stent implantationThomas Gremmel, Sabine Steiner, Daniela Seidinger, et al.
International Journal of Cardiology|May 7, 2011
A high maintenance dose increases the inhibitory response to clopidogrel in patients with high on-treatment residual platelet reactivityThomas Gremmel, Sabine Steiner, Daniela Seidinger, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|January 24, 2013
Obesity is associated with poor response to clopidogrel and an increased susceptibility to protease activated receptor-1 mediated platelet activationThomas Gremmel, Sabine Steiner, Daniela Seidinger, et al.
Cytotherapy|June 19, 2012
Processing of autologous bone marrow cells by apheresis technology for cell-based cardiovascular regenerationMarkus Dettke, Gerda Leitner, Christoph W Kopp, et al.
Journal of Cardiovascular Pharmacology|August 24, 2010
The influence of proton pump inhibitors on the antiplatelet potency of clopidogrel evaluated by 5 different platelet function testsThomas Gremmel, Sabine Steiner, Daniela Seidinger, et al.
Thrombosis Research|May 31, 2011
The influencing factors for clopidogrel-mediated platelet inhibition are assay-dependentThomas Gremmel, Sabine Steiner, Daniela Seidinger, et al.
Angiology|February 11, 2016
The Antiplatelet Effect of Clopidogrel Decreases With Patient AgeEndri Xhelili, Beate Eichelberger, Christoph W Kopp, et al.
Wiener Klinische Wochenschrift|October 1, 1982
[Genital Chlamydia infections in female patients at risk of having sexually transmitted diseases]A Stary, W Gebhart, W Gross, et al.
Pageof 19

Showing results (91-100 of 187) with videos related to

Sort By:
Pageof 19
Thrombosis and Haemostasis|November 8, 2013
In vivo and protease-activated receptor-1-mediated platelet activation but not response to antiplatelet therapy predict two-year outcomes after peripheral angioplasty with stent implantationT Gremmel, S Steiner, D Seidinger, et al.
Ecology|January 25, 2024
Fire sparks upslope range shifts of North Cascades plant speciesRachel N Wilson, Christopher W Kopp, Janneke Hille Ris Lambers, et al.
Platelets|January 15, 2011
Comparison of methods to evaluate aspirin-mediated platelet inhibition after percutaneous intervention with stent implantationThomas Gremmel, Sabine Steiner, Daniela Seidinger, et al.
International Journal of Cardiology|May 7, 2011
A high maintenance dose increases the inhibitory response to clopidogrel in patients with high on-treatment residual platelet reactivityThomas Gremmel, Sabine Steiner, Daniela Seidinger, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|January 24, 2013
Obesity is associated with poor response to clopidogrel and an increased susceptibility to protease activated receptor-1 mediated platelet activationThomas Gremmel, Sabine Steiner, Daniela Seidinger, et al.
Cytotherapy|June 19, 2012
Processing of autologous bone marrow cells by apheresis technology for cell-based cardiovascular regenerationMarkus Dettke, Gerda Leitner, Christoph W Kopp, et al.
Journal of Cardiovascular Pharmacology|August 24, 2010
The influence of proton pump inhibitors on the antiplatelet potency of clopidogrel evaluated by 5 different platelet function testsThomas Gremmel, Sabine Steiner, Daniela Seidinger, et al.
Thrombosis Research|May 31, 2011
The influencing factors for clopidogrel-mediated platelet inhibition are assay-dependentThomas Gremmel, Sabine Steiner, Daniela Seidinger, et al.
Angiology|February 11, 2016
The Antiplatelet Effect of Clopidogrel Decreases With Patient AgeEndri Xhelili, Beate Eichelberger, Christoph W Kopp, et al.
Wiener Klinische Wochenschrift|October 1, 1982
[Genital Chlamydia infections in female patients at risk of having sexually transmitted diseases]A Stary, W Gebhart, W Gross, et al.
Pageof 19